EP009

CAS No. 1462951-30-9

EP009( EP-009 | EP 009 )

Catalog No. M11987 CAS No. 1462951-30-9

A selective, orally active JAK3 inhibitor that reduces IL-2-mediated JAK3 tyrosine phosphorylation with cellular IC50 of 10-20 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EP009
  • Note
    Research use only, not for human use.
  • Brief Description
    A selective, orally active JAK3 inhibitor that reduces IL-2-mediated JAK3 tyrosine phosphorylation with cellular IC50 of 10-20 uM.
  • Description
    A selective, orally active JAK3 inhibitor that reduces IL-2-mediated JAK3 tyrosine phosphorylation with cellular IC50 of 10-20 uM; exhibits limited off-target effects against a panel of 92 human kinases; inhibits tyrosine phosphorylation and activation of JAK3/STAT3 in SU-DHL-1 cells, with activation of JNK1/2, but not p38; displays a favorable cytotoxicity profile with therapeutic efficacy against JAK3-driven tumor T-cells in vitro, in vivo, and ex vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    EP-009 | EP 009
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    JAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1462951-30-9
  • Formula Weight
    224.344
  • Molecular Formula
    C14H24O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C(CO)CCCCCCCCCC1=C
  • Chemical Name
    2-(hydroxymethyl)-12-methylenecyclododecanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ross JA, et al. Leukemia. 2014 Apr;28(4):941-4. 2. Martinez GS, et al. Clin Cancer Drugs. 2016;3(2):131-137.
molnova catalog
related products
  • GLPG-0634

    A potent JAK1/JAK2 inhibitor with IC50 of 10 nM/28 nM in biochemical assays; less potent for JAK3 and TYK2.

  • Tyk2-IN-30

    TYK2-IN-30 is a potent, selective and orally active Tyk2 inhibitor with Ki of 0.7 nM.

  • ZT55

    ZT55 (JAK inhibitor ZT55) is a novel potent, highly-selective tyrosine kinase JAK2 inhibitor with IC50 of 31 nM.